Alzheimer's disease (AD), commonly known as senile dementia, is a neurodegenerative disorder with an insidious onset and a progressive course. Its clinical manifestations include memory loss, anomic aphasia, confusion, impaired judgment, decline in activities of daily living and other brain dysfunctions, accompanied by personality and behavioral changes that seriously interfere with normal life. It is the most common cause of dementia. Its core pathological features are amyloid-beta plaque deposition and tau neurofibrillary tangles in the brain, which ultimately lead to neuronal death and brain atrophy.
As the disease progresses, all patients with Alzheimer's disease require round-the-clock care in the middle and late stages. With the accelerating aging of the global population, the number of patients continues to rise, and Alzheimer's disease has become one of the diseases with the highest medical costs and the heaviest care burden worldwide.
What other types of dementia affect older adults?
Dementia in older adults is not a single disease but a syndrome caused by declining brain function in people typically aged 65 and above. It is characterized by impairment in multiple domains such as memory, cognition and behavior, and in severe cases can lead to a complete loss of independence. Clinically, it is mainly divided into three subtypes:
Alzheimer's disease: accounts for 60%-80% of all dementia cases, with an insidious onset and slow progression, and is associated with abnormal protein deposition in the brain.
Vascular dementia: the second most common subtype, mainly caused by cerebrovascular lesions such as stroke and cerebral hypoperfusion; symptoms fluctuate as the cerebrovascular lesions worsen.
Dementia with Lewy bodies: typically characterized by fluctuating cognitive impairment, recurrent visual hallucinations and parkinsonian bradykinesia, with relatively faster disease progression.
Is forgetfulness the same as Alzheimer's disease?
Many middle-aged and older adults experience forgetfulness, and it is often difficult to distinguish benign age-related forgetfulness from Alzheimer's disease. The following criteria can help:
Difference in memory loss: benign forgetfulness involves partial forgetting of past events; memory loss caused by Alzheimer's disease is complete, as if the event never happened, like an eraser wiping away all memories.
Cognitive orientation: older adults with simple forgetfulness retain full orientation to time, place, people and surroundings; patients with Alzheimer's disease develop disorientation, such as being unable to tell the current season or find their way home.
Impact on daily living: people with mild forgetfulness remain fully independent; patients with Alzheimer's disease gradually lose independent living skills as symptoms worsen.
Personality changes: benign forgetfulness does not change a person's character or temperament; patients with Alzheimer's disease often show dramatic personality changes, and family members often describe them as a completely different person.
Changes in thinking: people with ordinary forgetfulness are troubled by memory gaps and adopt coping strategies such as taking notes; patients with Alzheimer's disease are not distressed by their cognitive deficits and show progressively slower thinking and reactions.
Can young people develop Alzheimer's disease?
Alzheimer's disease is trending toward younger onset. Globally, early-onset Alzheimer's disease (symptoms before age 65) accounts for about 5%-10% of all cases. According to the 2023 Alzheimer's Patient Needs Insight Report released by the Alzheimer's Disease Branch of the China Aging Wellbeing Association, about 21.3% of Alzheimer's patients in China develop symptoms before age 60.
Fewer than 5% of patients carry pathogenic mutations in APP, PSEN1 or PSEN2. These mutations lead to excessive amyloid production, with clinical manifestations before age 65 and in some cases as early as 40-50 years of age; this is familial Alzheimer's disease. In addition to genetic forms, early-onset Alzheimer's disease is closely associated with vascular risk factors (hypertension, hyperglycemia, hyperlipidemia), inflammation, and the potential influence of susceptibility genes such as ApoE, ABCA7 and TREM2.
What is mild cognitive impairment and how is it related to Alzheimer's disease?
Mild cognitive impairment (MCI) is an intermediate stage between normal cognition and dementia. It manifests as mild decline in cognitive domains such as memory, learning, language, attention, executive function or visuospatial ability, while basic activities of daily living remain unaffected. MCI can be divided into amnestic and non-amnestic types:
People with MCI have a significantly increased risk of progressive cognitive decline or progression to dementia, which may be Alzheimer's dementia or other subtypes such as vascular dementia or frontotemporal dementia. At the same time, MCI is a critical window for therapeutic intervention. About one quarter of patients can achieve reversal of cognitive function through timely and comprehensive early intervention, including lifestyle adjustment, medication and cognitive training. Seizing this golden window can delay or even reverse disease progression, relieve symptoms and improve quality of life.
What are the stages of Alzheimer's disease?
Alzheimer's disease is a continuous pathological spectrum with an insidious onset; pathological changes in brain neurons begin 15-20 years before obvious clinical symptoms appear. The 2024 NIH-AA Diagnostic and Staging Criteria for Alzheimer's Disease, issued by the U.S. National Institutes of Health and the Alzheimer's Association, divides the disease into 7 stages:
Stage 0: No clinical symptoms and normal biomarker levels, but confirmed as a carrier of a pathogenic gene.
Stage 1: No clinical symptoms, but core biomarkers (amyloid and tau) are positive.
Stage 2: Subjective cognitive decline; the individual perceives subtle cognitive changes but objective cognitive assessment is normal.
Stage 3: Mild cognitive impairment; objective cognitive tests are abnormal.
Stage 4: Mild dementia. Cognitive impairment affects complex instrumental activities of daily living (operating complex appliances, shopping, managing finances, socializing), while basic self-care such as dressing, eating and washing is preserved.
Stage 5: Moderate dementia; cognitive impairment continues to progress and the patient needs assistance with basic daily tasks.
Stage 6: Severe dementia; the patient is completely dependent on others for round-the-clock care.
The updated diagnostic criteria shift clinical assessment from probable diagnosis to pathological confirmation, opening an era of precise early diagnosis that supports timely intervention and treatment to slow disease progression.